EPISODE · Dec 9, 2024 · 6 MIN
Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights
from Curie: Healthcare in Focus
On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.
NOW PLAYING
Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m